Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
In malignant cancers, molecularly targeted therapy is attractive because it may not cause the side effects usually associated with chemotherapy. The search for proteins that inhibit the regulation of multiple oncogenic pathways is particularly urgent because tumor cells have many selective ways to survive and proliferate, and blocking only one molecular pathway may be futile.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
